Belgium· BE-AMP-SAM369774-00
Combodart 0.5 mg - 0.4 mg
A tamsulosin and dutasteride product containing tamsulosin hydrochloride, registered in Belgium by GlaxoSmithKline Pharmaceuticals. The same ATC class is registered in 13 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Tamsulosin and dutasteride is registered in 13 of 19 countries.
Countries holding a registration under ATC G04CA52 (tamsulosin and dutasteride), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Tamsulosin and dutasteride · ATC G04CA52
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tamsulosin Hydrochloride
- Manufacturer
- GlaxoSmithKline Pharmaceuticals
- Country
- Belgium (BE)
- ATC code
- G04CA52
- ATC class
- Tamsulosin and dutasteride
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb2697993
- be_apb2719474
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for tamsulosin and dutasteride.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tamsulosin and dutasteride · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Tamsulosin and dutasteride in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFOKUSINZentiva, k.s., Praha
- United Statestamsulosin hydrochlorideSandoz Inc
- SpainINREQ 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFGLaboratorios Q Pharma S.L.
- United KingdomAlphacard MR 400microgram capsulesRatiopharm UK Ltd
- FinlandExprosAstellas Pharma a/s
- PolandAdatamAdamed Pharma S.A.
- ItalyANTUNESFIDIA SPECIALTY S.R.L.
- GermanyOmnic OcasAstellas Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aglandin Retard, Tamsu
- Bulgaria · Tamaliz, Омник Токас
- Cyprus · Tamsulijn, Tamsulosin Aurobindo
- Czechia · Fokusin, Lannatam
- Germany · Omnic Ocas, Prostadil
- Denmark · Bladasin, Miktosan
- Estonia · Flosin, Omsal
- Spain · Inreq, Omnic
- Finland · Expros, Omnic Ocas
- France · Mecir L.P., Omexel L.P.
- United Kingdom (Northern Ireland) · Contiflo Xl, Cositam Xl
- Greece · Omnic Τocas, Prosolvin
- Croatia · Bazetham, Flosin
- Hungary · Galebon, Omnic
- Ireland · Omnexel, Tamnexyl Xl
- Iceland · Tamsulosin Hydrochloride Synthon, Tamsulosin Medical
- Italy · Antunes, Botam
- Lithuania · Flosin, Fokusin
- Luxembourg · Omic Ocas, Ranomax
- Latvia · Fokusin, Tamsulosin Lannacher
- Malta · Tamnic, Tamnic 400 Micrograms Modified-Release Capsules, Hard
- Netherlands · Duktam, Omnic 0,4
- Norway · Miktosan, Omnic
- Poland · Adatam, Adatam Xr
- Portugal · Omnic, Sebrane Xr
- Romania · Contiflo Mr, Fokusin
- Sweden · Tamicten
- Slovenia · Miktan, Omnic Ocas
- Slovakia · Fokusin, Geroprostan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/becf5d19-064f-4add-9461-98fc89b55732 GET /v1/drugs/becf5d19-064f-4add-9461-98fc89b55732?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Combodart 0.5 mg - 0.4 mg",
"name_fr": "Combodart 0.5 mg - 0.4 mg",
"name_nl": "Combodart 0.5 mg - 0.4 mg",
"amp_code": "SAM369774-00",
"strengths": [
"0.4000",
"0.3670",
"0.5000",
"0.0300",
"66.3200"
],
"pack_count": 3,
"substances": [
"Tamsulosin Hydrochloride",
"Tamsulosin",
"Dutasteride",
"Butylhydroxytoluene",
"E 110",
"Glycerol",
"Potassium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Tamsulosin and Dutasteride",
"authorisation_numbers": [
"BE369774"
]
}See everything about tamsulosin and dutasteride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.